ECG measurement: Simultaneous recording of a single-lead ECG signal with the Withings Move ECG and ECG signal for the reference 12-lead ECG
Study summary
Withings Move ECG watch is designed to record ECG and detect automatically atrial fibrillation. The aim of this study is to validate the performance of Move ECG watch to detect atrial fibrillation compared to a reference 12-lead ECG.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* male or female who are 18 years or older
* Subject who signed the written informed consent form
Exclusion Criteria:
* Vulnerable subject with regard to regulations
* Pregnant, parturient or breastfeeding woman,
* Subject who is deprived of liberty by judicial, medical or administrative decision,
* Underage subject,
* Legally protected subject, or subject who is unable to sign the written informed consent form,
* Subject who is not beneficiary or not affiliated to a social security scheme,
* Subject within several of the above categories,
* Subject who refused to participate in the study,
* Subject in physical incapacity to wear a wrist-worn watch
* Subject with electrical stimulation by pacemaker
Primary outcome measure(s)
Sensitivity and Specificity of the automatic classification in AF by Move ECG single-lead ECG against reference 12-lead ECG — 1 year sensitivity from the 2x2 confusion matrix AF vs 'non-AF'
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.